Evaluation of gentamicin pharmacokinetics and dosing protocols in 195 neonates

John E Murphy, Mauricio L. Austin, Reginald F. Frye

Research output: Contribution to journalArticle

30 Citations (Scopus)

Abstract

Gentamicin pharmacokinetics and dosing protocols in neonates were studied. Demographic and pharmacokinetic data on 202 neonates treated with gentamicin at a 500-bed medical center were collected over a three-year period. Administered doses, gentamicin concentration measurements, and recorded times were used to calculate each patient's clearance, volume of distribution, elimination rate constant, and half-life. The performance of 15 dosing protocols, inducing 6 previously published ones and 9 developed on the basis of the study, was evaluated using the pharmacokinetic data. Of the 202 patients, 195 were included in the analysis. The mean ± S.D. clearance, volume of distribution, elimination rate constant, and half-life were 0.047 ± 0.015 L/hr/kg, 0.45 ± 0.11 L/kg, 0.107 ± 0.032 L/hr, and 7.19 ± 2.64 hours, respectively. Weight, urine output, gestational age, and postconceptional age (PCA) had the highest correlation with the pharmacokinetic values. Blood urea nitrogen concentration (BUN) and Apgar score were poor predictors of the pharmacokinetic values. There were no significant differences among patient subsets based on race and BUN, but subset analysis based on PCA did indicate significant differences. In simulations, the protocols based on the study patients tended to perform better than the literature protocols, with all but three achieving therapeutic goals in 75% or more of the neonates. Of the published protocols, Murphy and Carter's produced the greatest percentage of neonates with peaks from 5 to 10 mg/L and troughs of <2 mg/L. The devised protocols tended to perform poorly in producing troughs between 1 and 2 mg/L, yet performed comparatively well in providing therapeutic peaks from 5 to 10 mg/L.

Original languageEnglish (US)
Pages (from-to)2280-2288
Number of pages9
JournalAmerican Journal of Health-System Pharmacy
Volume55
Issue number21
StatePublished - Nov 1 1998

Fingerprint

Gentamicins
Pharmacokinetics
Newborn Infant
Blood Urea Nitrogen
Half-Life
Apgar Score
Gestational Age
Demography
Urine
Weights and Measures
Therapeutics

Keywords

  • Age
  • Aminoglycosides
  • Blood levels
  • Dosage schedules
  • Drugs, body distribution
  • Excretion
  • Gentamicin
  • Half- life
  • Pediatrics
  • Pharmacokinetics
  • Protocols
  • Weight

ASJC Scopus subject areas

  • Pharmaceutical Science
  • Leadership and Management

Cite this

Evaluation of gentamicin pharmacokinetics and dosing protocols in 195 neonates. / Murphy, John E; Austin, Mauricio L.; Frye, Reginald F.

In: American Journal of Health-System Pharmacy, Vol. 55, No. 21, 01.11.1998, p. 2280-2288.

Research output: Contribution to journalArticle

Murphy, John E ; Austin, Mauricio L. ; Frye, Reginald F. / Evaluation of gentamicin pharmacokinetics and dosing protocols in 195 neonates. In: American Journal of Health-System Pharmacy. 1998 ; Vol. 55, No. 21. pp. 2280-2288.
@article{e1847f5dae3c4562bfef3c4e5e203292,
title = "Evaluation of gentamicin pharmacokinetics and dosing protocols in 195 neonates",
abstract = "Gentamicin pharmacokinetics and dosing protocols in neonates were studied. Demographic and pharmacokinetic data on 202 neonates treated with gentamicin at a 500-bed medical center were collected over a three-year period. Administered doses, gentamicin concentration measurements, and recorded times were used to calculate each patient's clearance, volume of distribution, elimination rate constant, and half-life. The performance of 15 dosing protocols, inducing 6 previously published ones and 9 developed on the basis of the study, was evaluated using the pharmacokinetic data. Of the 202 patients, 195 were included in the analysis. The mean ± S.D. clearance, volume of distribution, elimination rate constant, and half-life were 0.047 ± 0.015 L/hr/kg, 0.45 ± 0.11 L/kg, 0.107 ± 0.032 L/hr, and 7.19 ± 2.64 hours, respectively. Weight, urine output, gestational age, and postconceptional age (PCA) had the highest correlation with the pharmacokinetic values. Blood urea nitrogen concentration (BUN) and Apgar score were poor predictors of the pharmacokinetic values. There were no significant differences among patient subsets based on race and BUN, but subset analysis based on PCA did indicate significant differences. In simulations, the protocols based on the study patients tended to perform better than the literature protocols, with all but three achieving therapeutic goals in 75{\%} or more of the neonates. Of the published protocols, Murphy and Carter's produced the greatest percentage of neonates with peaks from 5 to 10 mg/L and troughs of <2 mg/L. The devised protocols tended to perform poorly in producing troughs between 1 and 2 mg/L, yet performed comparatively well in providing therapeutic peaks from 5 to 10 mg/L.",
keywords = "Age, Aminoglycosides, Blood levels, Dosage schedules, Drugs, body distribution, Excretion, Gentamicin, Half- life, Pediatrics, Pharmacokinetics, Protocols, Weight",
author = "Murphy, {John E} and Austin, {Mauricio L.} and Frye, {Reginald F.}",
year = "1998",
month = "11",
day = "1",
language = "English (US)",
volume = "55",
pages = "2280--2288",
journal = "American Journal of Health-System Pharmacy",
issn = "1079-2082",
publisher = "American Society of Health-Systems Pharmacy",
number = "21",

}

TY - JOUR

T1 - Evaluation of gentamicin pharmacokinetics and dosing protocols in 195 neonates

AU - Murphy, John E

AU - Austin, Mauricio L.

AU - Frye, Reginald F.

PY - 1998/11/1

Y1 - 1998/11/1

N2 - Gentamicin pharmacokinetics and dosing protocols in neonates were studied. Demographic and pharmacokinetic data on 202 neonates treated with gentamicin at a 500-bed medical center were collected over a three-year period. Administered doses, gentamicin concentration measurements, and recorded times were used to calculate each patient's clearance, volume of distribution, elimination rate constant, and half-life. The performance of 15 dosing protocols, inducing 6 previously published ones and 9 developed on the basis of the study, was evaluated using the pharmacokinetic data. Of the 202 patients, 195 were included in the analysis. The mean ± S.D. clearance, volume of distribution, elimination rate constant, and half-life were 0.047 ± 0.015 L/hr/kg, 0.45 ± 0.11 L/kg, 0.107 ± 0.032 L/hr, and 7.19 ± 2.64 hours, respectively. Weight, urine output, gestational age, and postconceptional age (PCA) had the highest correlation with the pharmacokinetic values. Blood urea nitrogen concentration (BUN) and Apgar score were poor predictors of the pharmacokinetic values. There were no significant differences among patient subsets based on race and BUN, but subset analysis based on PCA did indicate significant differences. In simulations, the protocols based on the study patients tended to perform better than the literature protocols, with all but three achieving therapeutic goals in 75% or more of the neonates. Of the published protocols, Murphy and Carter's produced the greatest percentage of neonates with peaks from 5 to 10 mg/L and troughs of <2 mg/L. The devised protocols tended to perform poorly in producing troughs between 1 and 2 mg/L, yet performed comparatively well in providing therapeutic peaks from 5 to 10 mg/L.

AB - Gentamicin pharmacokinetics and dosing protocols in neonates were studied. Demographic and pharmacokinetic data on 202 neonates treated with gentamicin at a 500-bed medical center were collected over a three-year period. Administered doses, gentamicin concentration measurements, and recorded times were used to calculate each patient's clearance, volume of distribution, elimination rate constant, and half-life. The performance of 15 dosing protocols, inducing 6 previously published ones and 9 developed on the basis of the study, was evaluated using the pharmacokinetic data. Of the 202 patients, 195 were included in the analysis. The mean ± S.D. clearance, volume of distribution, elimination rate constant, and half-life were 0.047 ± 0.015 L/hr/kg, 0.45 ± 0.11 L/kg, 0.107 ± 0.032 L/hr, and 7.19 ± 2.64 hours, respectively. Weight, urine output, gestational age, and postconceptional age (PCA) had the highest correlation with the pharmacokinetic values. Blood urea nitrogen concentration (BUN) and Apgar score were poor predictors of the pharmacokinetic values. There were no significant differences among patient subsets based on race and BUN, but subset analysis based on PCA did indicate significant differences. In simulations, the protocols based on the study patients tended to perform better than the literature protocols, with all but three achieving therapeutic goals in 75% or more of the neonates. Of the published protocols, Murphy and Carter's produced the greatest percentage of neonates with peaks from 5 to 10 mg/L and troughs of <2 mg/L. The devised protocols tended to perform poorly in producing troughs between 1 and 2 mg/L, yet performed comparatively well in providing therapeutic peaks from 5 to 10 mg/L.

KW - Age

KW - Aminoglycosides

KW - Blood levels

KW - Dosage schedules

KW - Drugs, body distribution

KW - Excretion

KW - Gentamicin

KW - Half- life

KW - Pediatrics

KW - Pharmacokinetics

KW - Protocols

KW - Weight

UR - http://www.scopus.com/inward/record.url?scp=0032213003&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032213003&partnerID=8YFLogxK

M3 - Article

C2 - 9825879

AN - SCOPUS:0032213003

VL - 55

SP - 2280

EP - 2288

JO - American Journal of Health-System Pharmacy

JF - American Journal of Health-System Pharmacy

SN - 1079-2082

IS - 21

ER -